R-7025

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameR-7025
Drug Alias NameR-7025RO-5014583Maxy-24Maxy-alpha
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterferon alpha stimulants
TargetsInterferon alpha
Therapy Area/IndicationsHepatitis CHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMaxygen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMaxygen
Active IndicationsN/A
Inactive IndicationsHepatitis CHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A